Terms: = Colorectal cancer AND UBR5, EDD, 51366, ENSG00000104517, EDD1, KIAA0896, HYD, MGC57263, DD5, O95071, FLJ11310
12 results:
1. Inhibition of CDK1 Overcomes Oxaliplatin Resistance by Regulating ACSL4-mediated Ferroptosis in colorectal cancer.
Zeng K; Li W; Wang Y; Zhang Z; Zhang L; Zhang W; Xing Y; Zhou C
Adv Sci (Weinh); 2023 Sep; 10(25):e2301088. PubMed ID: 37428466
[TBL] [Abstract] [Full Text] [Related]
2. Antioxidant, Immunostimulatory, and Anticancer Properties of hydrolyzed Wheat Bran Mediated through Macrophages Stimulation.
Tomé-Sánchez I; Martínez-Villaluenga C; Martín-Diana AB; Rico D; Jiménez-Pulido I; Frias J; Dia VP
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108599
[TBL] [Abstract] [Full Text] [Related]
3. The role and molecular mechanism of metabolic reprogramming of colorectal cancer by ubr5 through PYK2 regulation of OXPHOS expression study.
Qin R; Huang Y; Yao Y; Wang L; Zhang Z; Huang W; Su Y; Zhang Y; Guan A; Wang H
J Biochem Mol Toxicol; 2023 Aug; 37(8):e23376. PubMed ID: 37098808
[TBL] [Abstract] [Full Text] [Related]
4. Sequential-delivery nanocomplex for combined anti-angiogenesis and gene therapy against colorectal cancer.
Jia F; Li Y; Gao Y; Wang X; Lu J; Cui X; Pan Z; Xu C; Deng X; Wu Y
Int J Pharm; 2023 Apr; 637():122850. PubMed ID: 36990169
[TBL] [Abstract] [Full Text] [Related]
5. Reducing hospital stay for colorectal surgery in ERAS setting by means of perioperative patient education of expected day of discharge.
Tweed TTT; Woortman C; Tummers S; Bakens MJAM; van Bastelaar J; Stoot JHMB
Int J Colorectal Dis; 2021 Jul; 36(7):1535-1542. PubMed ID: 33977333
[TBL] [Abstract] [Full Text] [Related]
6. Folate-PEG/hyd-curcumin/C18-g-PSI micelles for site specific delivery of curcumin to colon cancer cells via Wnt/β-catenin signaling pathway.
Le TT; Kim D
Mater Sci Eng C Mater Biol Appl; 2019 Aug; 101():464-471. PubMed ID: 31029341
[TBL] [Abstract] [Full Text] [Related]
7. Mitochondria and nucleus delivery of active form of 10-hydroxycamptothecin with dual shell to precisely treat colorectal cancer.
Li HQ; Ye WL; Huan ML; Cheng Y; Liu DZ; Cui H; Liu M; Zhang BL; Mei QB; Zhou SY
Nanomedicine (Lond); 2019 Apr; 14(8):1011-1032. PubMed ID: 30925116
[TBL] [Abstract] [Full Text] [Related]
8. Comprehensive Analysis of Somatic Mutations in colorectal cancer With Peritoneal Metastasis.
Lee JH; Ahn BK; Baik SS; Lee KH
In Vivo; 2019; 33(2):447-452. PubMed ID: 30804124
[TBL] [Abstract] [Full Text] [Related]
9. ubr5 promotes cell proliferation and inhibits apoptosis in colon cancer by destablizing P21.
Ji SQ; Zhang YX; Yang BH
Pharmazie; 2017 Jul; 72(7):408-413. PubMed ID: 29441938
[TBL] [Abstract] [Full Text] [Related]
10. ubr5 Contributes to colorectal cancer Progression by Destabilizing the Tumor Suppressor ECRG4.
Wang J; Zhao X; Jin L; Wu G; Yang Y
Dig Dis Sci; 2017 Oct; 62(10):2781-2789. PubMed ID: 28856538
[TBL] [Abstract] [Full Text] [Related]
11. Putative tumor suppressor edd interacts with and up-regulates APC.
Ohshima R; Ohta T; Wu W; Koike A; Iwatani T; Henderson M; Watts CK; Otsubo T
Genes Cells; 2007 Dec; 12(12):1339-45. PubMed ID: 18076571
[TBL] [Abstract] [Full Text] [Related]
12. Is diverticulosis associated with colorectal neoplasia? A cross-sectional colonoscopic study.
Kieff BJ; Eckert GJ; Imperiale TF
Am J Gastroenterol; 2004 Oct; 99(10):2007-11. PubMed ID: 15447764
[TBL] [Abstract] [Full Text] [Related]